|
Hello,
As part of our ongoing commitment to share important decisions and recommendations with you, below is a summary of today’s Advisory Committee on Immunization Practices (ACIP) meeting and subsequent vote.
The ACIP met today, February 28, to discuss and vote on recommendations for the Janssen COVID-19 vaccine. The ACIP members received an update on the safety and efficacy data for the Janssen COVID-19 vaccine. The members then used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach to develop recommendations.
Recommendations
The committee members voted to recommend that “The Janssen COVID-19 vaccine is recommended for persons 18 years of age and older in the U.S. population under the FDA’s Emergency Use Authorization.”
The recommendation should be implemented in the context of current CDC allocation recommendations.
Impact on IIS
The Clinical Decision Support for Immunization (CDSi) rules are currently being developed and reviewed. The draft version will be released soon, and the official version will become available shortly after publication of the Morbidity and Mortality Weekly Report.
The next scheduled ACIP meeting is tomorrow, March 1 from 11 a.m. to 3:00 p.m. ET.
|
